Accelerating Antibody Drug Discovery with AI-Integrated Tools

“Our mission at OmniAb is to enable the rapid development of innovative therapeutics by pushing the frontiers of drug discovery technologies – and we do that through a blending of our in silico, in vitro, and in vivo competencies. OmniDeep™ is a suite of in silico, AI and machine learning tools that we leverage to realize the full potential of the naturally-optimized immune repertoires produced in our transgenic animals. This integration enables us to deeply mine a vast antibody sequence space aided by in vitro phenotypic screening and next generation sequencing data, and our technologies are designed to discover best-in-class antibody candidates with our industry and academic partners.” Antibodies are a rapidly growing class of drugs used in high-value and high-impact therapeutic areas like oncology, autoimmunity, inflammation, infectious diseases, and more. W... Read more